Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age

Thrombosis and Haemostasis

Volumn 94, Issue 1, 2005, Pages 101-106

  Arsène, Sophie ^a   Delahousse, Bénédicte ^b   Regina, Sandra ^b,c   Le Lez, Marie Laure ^a   Pisella, Pierre Jean ^a   Gruel, Yves ^b,c  

^a CHU BRETONNEAU   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c INSERM   (France)

Author keywords

Factor V Leiden; Hereditary thrombosis risk factors; Retinal vein occlusion

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ANGINA PECTORIS; ANTITHROMBIN DEFICIENCY; ARTICLE; CAUCASIAN; CHI SQUARE TEST; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GLAUCOMA; HETEROZYGOSITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA VEIN OCCLUSION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTITHROMBINS; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; PROTHROMBIN; RETINAL VEIN OCCLUSION; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; TIME FACTORS;

EID: 22144439432     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-10-0659     Document Type: Article

References (32)

1. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1996; 114: 545-54.
2. Arsene S, Giraudeau B, Le Lez ML, et al. Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol 2002; 86: 1243-7.
3. Tranquart F, Arsene S, Giraudeau B, et al. Initial color Doppler findings in retinal vein occlusion. J Clin Ultrasound 2000; 28: 28-33.
4. Fegan CD. Central retinal vein occlusion and thrombophilia. Eye 2002; 16: 98-106.
5. Tranquart F, Arsene S, Aubert-Urena AS, et al. Doppler assessment of hemodynamic changes after hemodilution in retinal vein occlusion. J Clin Ultrasound 1998; 26: 119-24.
6. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 286-90.
7. Lahey JM, Kearney JJ, Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 2003; 9: 385-92.
8. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
9. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989; 73: 895-9.
10. Chen HC, Wiek J, Gupta A, et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998; 82: 162-7.
11. Ripoll L, Paulin D, Thomas S, et al. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1997; 78: 960-1.
12. Prisco D, Marcucci R, Bertini L, et al. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002; 13: 163-9.
13. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90: 1004-8.
14. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
15. Albisinni R, Coppola A, Loffredo M, et al. Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 1998; 80: 702-3.
16. Glueck CJ, Bell H, Vadlamani L, et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999; 117: 43-9.
17. Greiner K, Peetz D, Winkgen A, et al. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999; 23: 155-60.
18. Greiner K, Hafner G, Dick B, et al. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999; 128: 69-74.
19. Kuhli C, Hattenbach LO, Scharrer I, et al. High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 163-8.
20. Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86: 772-6.
21. Graham SL, Goldberg I, Murray B, et al. Activated protein C resistance--low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust N Z J Ophthalmol 1996; 24: 199-205.
22. Linna T, Ylikorkala A, Kontula K, et al. Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 1997; 77: 214-6.
23. Salomon O, Moisseiev J, Rosenberg N, et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 1998; 9: 617-22.
24. Kalayci D, Gurgey A, Guven D, Parlak H, Hasiripi H. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 1999; 77: 622-4.
25. Lahey JM, Tunc M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002; 109: 126-31.
26. Delahousse B, Arsene S, Piquemal R, et al. The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion. Blood Coagul Fibrinolysis 1998; 9: 447-8.
27. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993; 37: 393-417.
28. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110: 118-23.
29. Hayreh SS, Zimmerman MB, Podhajsky P. Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 180-96.
30. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429-41.
31. Dodson PM, Kubicki AJ, Taylor KG, et al. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophthalmol 1985; 69: 493-6.
32. Spagnolo BV, Nasrallah FP. Bilateral retinal vein occlusion associated with factor V Leiden mutation. Retina 1998; 18: 377-8.